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Aortoesophageal fistula after thoracic endovascular
aortic repair and transthoracic embolization
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Endografts are more commonly being used to treat thoracic aortic aneurysms and other vascular lesions. Endoleaks are
a potential complication of this treatment modality and can be associated with aneurysmal sac expansion and rupture.
This case report presents a patient who developed a type IA endoleak after endograft repair of a descending thoracic
aneurysm. The endoleak was successfully treated through computed tomographic-guided transthoracic embolization,
although the patient experienced lower extremity paraparesis postprocedurally. The patient’s endovascular repair was
complicated by the development of an aortoesophageal fistula and endograft infection necessitating operative débride-
ment and endograft explantation. (J Vasc Surg 2007;46:789-91.)Thoracic endovascular aortic repair (TEVAR) is an
alternative to open surgical repair for the treatment of many
thoracic aortic lesions, but late complications of this form
of therapy can occur.1 Endoleaks are a potential complica-
tion and may indicate persistent systemic pressurization of
the aneurysm sac. Aortic endograft infections are rarely
reported and have been associated with secondary proce-
dures after endovascular abdominal aortic aneurysm repair
(EVAR).2
In this case report we present a patient with a type IA
endoleak after TEVAR successfully treated by computed
tomographic (CT)-guided embolization. An aortoesopha-
geal fistula and endograft infection developed. This report
highlights the technical feasibility of a transthoracic ap-
proach to endoleak management and raises a word of
caution regarding endograft infection as a potential com-
plication of TEVAR and subsequent secondary procedures.
CASE REPORT
A 52-year-old man with diabetes mellitus and hypertension
presented with chest pain. Chest radiographic findings were sug-
gestive of a thoracic aortic aneurysm. The patient was treated for
bronchitis and referred for further evaluation. CT angiography
(CTA) of the chest revealed a 6-cm descending thoracic aortic
aneurysm without evidence of inflammation or rupture. The pa-
tient underwent TEVAR and received three Gore TAG endografts
(W. L. Gore & Associates Inc, Flagstaff, Ariz), which were sized
according to the manufacturer’s instruction for use and deployed
with partial overlap of the left subclavian artery (SCA).
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doi:10.1016/j.jvs.2007.05.036At 1-month follow-up, the patient reported left lateral chest
pain radiating to his back, and CTA revealed contrast outside
the proximal portion of the endograft on delayed images sug-
gestive of a type IA or type II endoleak. The proximal endograft
appeared to be fully expanded with good circumferential appo-
sition. Observational management was initially used, but the
patient’s back pain became progressively worse during the next
6 weeks.
A repeat CTA demonstrated persistence of the endoleak.
Thoracic angiography confirmed a type IA endoleak that commu-
nicated with the aneurysm sac through an extremely narrow chan-
nel. Attempts to perform transarterial embolization were unsuc-
cessful owing to the inability to sufficiently advance multiple
microguidewires and microcatheters to obtain a stable position
necessary for embolization.
Because of persistent pain and a 2-mm increase in aneurysm
Fig 1. Computed tomographic-guided transthoracic access of
the aneurysm sac.diameter, transthoracic embolization was performed 3 months
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CT guidance was used to insert a 21-gauge needle into the
aneurysm (Fig 1). The needle was exchanged for a 6F sheath from
an AccuStick introducer system (Boston Scientific, Natick, Mass).
Injection of contrast demonstrated communication at the proxi-
mal attachment site, confirming a type IA endoleak. Draining
efferent intercostal arteries were also observed (Fig 2, A).
A 4F catheter was advanced through the 6F catheter into the
aneurysm and manipulated into the proximal region of the en-
dograft. Sixteen platinum Nester coils (Cook, Bloomington, Ind)
were placed (Fig 2, B). Additional embolization was performed
with a 1:3 mixture of Trufill glue (Cordis Neurovascular, Inc,
Miami Lakes, Fla) and Ethiodol (Savage Laboratories, Melville,
NY). A gel-foam slurry was used to embolize the needle tract as the
catheters were removed.
After the procedure, the patient presented with progressive
bilateral lower extremity paraparesis. Placement of a lumbar drain
did not improve symptoms.Magnetic resonance imaging (MRI) of
the thoracic and lumbar spine did not demonstrate evidence of
spinal cord ischemia. Two weeks after his secondary procedure, the
patient was transferred to an acute rehabilitation facility, and his
lower extremity symptoms improved.
Six weeks after the endoleak repair, the patient presented with
night sweats, fatigue, and chills. He denied chest pain, hemateme-
sis, hemoptysis, and dysphagia. CTA demonstrated perigraft and
aneurysmal sac air-fluid levels. A swallow study revealed contrast
extending into the aneurysm sac around the endograft.
The patient urgently underwent replacement of his descend-
ing thoracic aorta with a Dacron interposition graft (Boston Sci-
entific, Wayne, NJ) soaked in rifampin under cardiopulmonary
bypass and hypothermic circulatory arrest. The aorta was found to
be densely inflamed from the distal arch to the diaphragmatic
hiatus, with gross purulence. In addition, a 4-mm defect in the
middle esophagus communicated with the aneurysm. A large
defect in the mid-descending aorta with exposed endograft was
Fig 2. Angiography and embolization of a type IA end
revealed a type IA endoleak and efferent drainage througappreciated (Fig 3). The exposed endograft did not appear to beclose enough to the esophagus to have caused mechanical erosion.
The aneurysm remained excluded from the systemic circulation.
The defect in the esophagus was closed primarily in two layers.
Cultures of the aneurysm grew Staphylococcus aureus, Streptococcus
anginosus, and multiple anaerobic bacteria.
On hospital day 25, the patientwent into cardiopulmonary arrest
after an acute massive hemorrhage into his left chest. Emergent
exploration revealed hemorrhage from the proximal anastomosis.
. A, Direct injection of contrast into the aneurysm sac
rcostal vessels (arrow). B, Successful coil embolization.
Fig 3. Intraoperative photograph taken during aortoesophageal
repair and endograft explantation shows the esophagus is retracted
anteriorly and a defect in the aortic wall is appreciated with exposed
endograft.oleakDespite repair of the defect, the patient died intraoperatively.
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Successful TEVAR of descending thoracic aneurysms
involves exclusion of the aneurysm. Endoleaks represent a
persistent communication between the aneurysm and the
systemic arterial circulation that may contribute to sac
enlargement or rupture, or both.3,4 Type I endoleaks can
often be managed through balloon angioplasty or deploy-
ment of an additional endograft component when an ade-
quate landing zone is present. In the case reported here, an
additional endograft could not be placed because the pa-
tient’s left common carotid artery was too close to the left
SCA. Although an extra-anatomic bypass would have al-
lowed for proximal endograft deployment, this would have
necessitated a more invasive procedure. In addition, angio-
plasty was not felt to be beneficial in resolving a narrow
channel endoleak owing to the full expansion and good
apposition of the endograft.
CT-guided translumbar embolization of endoleaks af-
ter EVAR has been previously described using a variety of
embolic and thrombotic agents.5-8 Translumbar emboliza-
tion promotes thrombosis to decreasing mean aneurysm
sac pressure and eliminates blood outflow from efferent
branch vessels. This form of treatment has been advocated
instead of a transarterial approach for the treatment of type
II endoleaks after EVAR.7
The incidence of thoracic endograft infections is un-
known, but abdominal endograft infections are rare. A
combined survey and review of the literature from 1991 to
2002 by Ducasee et al2 reported an incidence of 0.43%.
When infections occurred after embolization procedures,
S aureus was identified as the infectious agent in 85% of the
cases. The presence of S aureus in the intraoperative cul-
tures is consistent with these observations and may suggest
a cutaneous source of the infection.
From the history, it is unclear how the patient’s en-
dograft became infected; either as a consequence of foreign
material deployed after TEVAR or secondary to contami-
nation from the transthoracic procedure. The patient’s
chest and back pain may have suggested a subacute infec-
tious aortitis, although CT imaging before and after theprocedure was not suggestive of this. In addition, although
the patient became symptomatic after the transthoracic
procedure, his presentation was rather subacute at 6 weeks.
Imaging after the procedure did not reveal ischemic
changes to the spinal cord, but the patient’s paraparesis was
most likely due to distal embolization of glue into efferent
aortic branch vessels. We elected to use coils and a mixture
of glue and contrast to more reliably embolize the aneu-
rysm sac. A less dilute mixture might have prevented this
complication from occurring.
CT-guided transthoracic embolization is a technically
feasible treatment approach for endoleaks after TEVAR.
Clinicians should also be aware of endograft infection as a
potential complication of TEVAR and subsequent second-
ary procedures.
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